To view this video, please enable marketing cookies from Cookie Preferences in the footer.
In this lecture from This is Why, Dr. Busti will explain how Long-Acting Beta Agonists (LABAs) work, where they fit in therapy for the management of asthma and COPD.
You’ll learn how to:
- Mechanism of action: beta-2 receptor activation → bronchodilation (airway smooth muscle relaxation)
- Clinical use: LABAs in COPD maintenance vs asthma (must be combined with ICS)
- Onset/duration differences and practical inhaler considerations
- Adverse effects & warnings: tachycardia, tremor, hypokalemia, paradoxical bronchospasm, and key safety concepts
- Therapeutic combos: ICS/LABA combination inhalers and where they fit (including common guideline concepts)
LABA drugs discussed for SEO/review:
- Salmeterol
- Formoterol
- Vilanterol
- Olodaterol
- Indacaterol
The goal = make medical education easy and clinically relevant.
Chapter Table of Contents
00:00 LABAs Overview: Role in Asthma & COPD Symptom Control (12–24 Hours)
03:03 Indications & Uses: Asthma, COPD, Exercise-Induced Bronchospasm
05:07 Asthma vs COPD Basics: Inflammation Type & Response to Bronchodilators/ICS
07:11 ACOS Explained: Asthma–COPD Overlap and Why It Matters for Therapy
09:16 Net Benefit: Better Daily/Nocturnal Symptoms + Lung Function, Fewer Visits
10:45 Why Delivery Matters: Getting Drug to Bronchioles (Not Oropharynx)
15:17 Pathophysiology Visuals: Asthma Bronchospasm vs COPD Mucus/Remodeling
17:40 Mechanism: Beta-2 → ↑cAMP/PKA → ↓Ca²⁺ & ↓Myosin Phosphorylation
21:04 Why “Long-Acting”: Lipid Solubility, Receptor Interaction, Selectivity
23:00 Dosing Patterns: 12-Hour (BID) vs Ultra-Long (QD) + Desensitization Concept
25:04 Inhaler Technique Pearls: MDI vs DPI vs Nebs + Spacer, Breath Hold 10 sec
30:55 Clinical Rules: No LABA Monotherapy in Asthma + Combo/Triple Therapy & Monitoring
If this helped you, please like, subscribe to our YouTube Channel, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.
Don’t forget to turn on notifications on YouTube so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!
#LABA #LongActingBetaAgonist #Asthma #Bronchodilators #busti
Speaker:
Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education.
Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes.
About This Channel:
This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC).
Disclaimer:
This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.
More than just access—it’s where understanding deepens.
Create a free account or log in to gain access to this content!
Related Topics
